This study is looking at a type of radiation therapy called aPBI (Accelerated Partial Breast Irradiation) for women who have had breast cancer return in the same breast after previous radiation. The aPBI treatment involves 30 Gy (Gray, a unit of radiation dose) given in 5 sessions using a VMAT (Volumetric Modulated Arc Therapy) technique. The main goal is to see if this re-irradiation treatment causes an acceptably low level of side effects within one year. Researchers also want to see how well it controls the cancer locally and to look at cosmetic results. You may be able to join if you are 40 or older, have a second breast cancer in the same breast diagnosed more than a year after your first treatment, have had prior radiation, and still have your breast. The study is currently unclear on its recruitment status and plans to enroll 30 participants.

Study design

This is an interventional study, meaning participants will receive a specific treatment. It plans to enroll 30 participants.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

Treatment-associated toxicity will be measured within one year after treatment.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.